Vimarsana
Biggest News Aggregation in the World

Page 8 - Wakefulness Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wakefulness Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wakefulness Test Today - Breaking & Trending Today

Pharmacologic Therapies Effective for Excessive Daytime Sleepiness - Vimarsana News

Pharmacologic Therapies Effective for Excessive Daytime Sleepiness

Solriamfetol, armodafinil-modafinil, and pitolisant reduce daytime sleepiness, with solriamfetol likely superior.

Source: empr.com
Daytime Sleepiness Drugs of Varying Performance in Obstructive Sleep Apnea - Vimarsana News

Daytime Sleepiness Drugs of Varying Performance in Obstructive Sleep Apnea

Solriamfetol had particularly strong showing in network meta-analysis

FDA Approves Once-Nightly Lumryz for Patients With Narcolepsy - Vimarsana News

FDA Approves Once-Nightly Lumryz for Patients With Narcolepsy

The FDA has granted final approval to Lumryz (sodium oxybate) for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy.

FDA Approves Once-Nightly Lumryz for Patients With Narcolepsy - Vimarsana News

FDA Approves Once-Nightly Lumryz for Patients With Narcolepsy

The FDA has granted final approval to Lumryz (sodium oxybate) for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy.

Source: empr.com
Harmony Biosciences Presents Post-Hoc Analysis Of WAKIX Pivotal Data In Adults With High Burden Of Narcolepsy Symptoms - Vimarsana News

Harmony Biosciences Presents Post-Hoc Analysis Of WAKIX Pivotal Data In Adults With High Burden Of Narcolepsy Symptoms

A SLEEP 2022 poster presents a post-hoc analysis of pooled data from patients in WAKIX pivotal clinical trials who had a high burden of narcolepsy.